S32826 disodium is primarily used in research and development, particularly in the field of pharmacology. It is known for its role as a selective antagonist of the TAAR1 receptor, which is involved in modulating neurotransmitter systems. This makes it a valuable tool in studying the physiological and pathological roles of TAAR1 in the central nervous system. Researchers utilize S32826 disodium to explore its potential therapeutic applications in conditions such as schizophrenia, depression, and addiction, as it may influence dopamine, serotonin, and norepinephrine pathways. Additionally, it aids in understanding the mechanisms of monoaminergic systems and their impact on behavior and mood regulation.